Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ferrucci

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 17, 2020
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life studyC Patruno, M Napolitano, G Argenziano, et al.
Acta Dermato-Venereologica|April 15, 2026
Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis)Elena Pezzolo, Rossi Mariateresa, Raul Armando Luyo Saboya, et al.
The Journal of Dermatological Treatment|October 10, 2024
Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study - il AD (Italian landscape atopic dermatitis)Luigi Gargiulo, Luciano Ibba, Angela Alfano, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 12, 2022
Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experienceL Stingeni, L Bianchi, E Antonelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 29, 2024
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort studyGianluca Avallone, Francesco Cavallo, Annalisa Tancredi, et al.
Clinical and Experimental Dermatology|July 15, 2025
Therapeutic Outcomes Across JAK Inhibitors in Prurigo NodularisGianluca Avallone, Andrea Bombelli, Luca Valtellini, et al.
Journal of the National Cancer Institute|August 9, 2024
Exercise and Nutrition to Improve Cancer Treatment-Related Outcomes (ENICTO)Kathryn H Schmitz, Justin C Brown, Melinda L Irwin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 9, 2024
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian studyB M Piraccini, F Pampaloni, S Cedirian, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 17, 2020
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life studyC Patruno, M Napolitano, G Argenziano, et al.
Acta Dermato-Venereologica|April 15, 2026
Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis)Elena Pezzolo, Rossi Mariateresa, Raul Armando Luyo Saboya, et al.
The Journal of Dermatological Treatment|October 10, 2024
Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study - il AD (Italian landscape atopic dermatitis)Luigi Gargiulo, Luciano Ibba, Angela Alfano, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 12, 2022
Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experienceL Stingeni, L Bianchi, E Antonelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 29, 2024
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort studyGianluca Avallone, Francesco Cavallo, Annalisa Tancredi, et al.
Clinical and Experimental Dermatology|July 15, 2025
Therapeutic Outcomes Across JAK Inhibitors in Prurigo NodularisGianluca Avallone, Andrea Bombelli, Luca Valtellini, et al.
Journal of the National Cancer Institute|August 9, 2024
Exercise and Nutrition to Improve Cancer Treatment-Related Outcomes (ENICTO)Kathryn H Schmitz, Justin C Brown, Melinda L Irwin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 9, 2024
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian studyB M Piraccini, F Pampaloni, S Cedirian, et al.
Pageof 14